Navigation Links
Federal Health IT Market to Reach $4.5 Billion by 2013
Date:2/21/2008

RESTON, Va., Feb. 21 /PRNewswire/ -- Federal Health Information Technology (IT) spending will grow from $3.2 billion in 2008 to over $4.5 billion in 2013 at a compound annual growth rate (CAGR) of 7.1%, which is faster than the overall Federal IT market, according to a new report by INPUT, the authority on government business.

"While 7% CAGR seems robust, several things remain in the way of even more rapid growth," said Lauren Jones, principal analyst at INPUT. "This market, as well as the national Health IT market as a whole, will accelerate after standards are adopted and the vast volume of medical records are digitized, enabling them to be shared among health care providers," said Jones.

The report, Federal Health IT Market: 2008 - 2013 examines the Federal Health IT trends and the evolutionary path the market is likely to take in the next five years, and identifies ways vendors can assist agencies as they lay the foundation for a modern, interoperable federal health care system. The report suggests that vendors can influence and possibly even accelerate the market by actively participating in standards development organizations, as well as by assisting agencies in modernizing their Health IT systems.

Additionally, the strain of dealing with a burgeoning patient population of Baby Boomers enrolling in the Medicare program, aging veterans, and returning military personnel will drive continued modernization, enhancement, and expansion of Federal Health IT Systems.

"Many Health Care processes still need to be automated or modernized over the next few years in order to realize cost savings and, more importantly, to create comprehensive patient electronic health records (EHRs) that can be used to improve the quality of health care," said John Slye, principal analyst at INPUT and co-author of the report.

Vendors with domain expertise in Health IT, specialized technology, and established qualifications and relationships with key
'/>"/>

SOURCE INPUT
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Greenway Medical Technologies Broadens Sales Efforts With Entrance Into Federally Qualified Health Center Marketplace
2. AOTA Gets Profession Addressed on House Floor in Federal Loan Repayment Bill
3. Bush Budget Cuts Federal Health Programs Vital to the Health of All Children
4. Merck Pays More Than $400 Million to Settle Federal, State Medicaid Fraud Investigation Sparked by Qui Tam Whistleblower Case Detailing Marketing Schemes for Vioxx(R), Zocor(R), Several Other Drugs
5. UTMB wins $3.4 million federal grant to study addiction-recovery drugs
6. Texas Health Care Association Urges Texas Congressional Delegation to Fight Planned Federal Cuts to Medicaid, Medicare
7. On Heels of SCHIP Veto, President Advocates Eliminating Federal Funding for Training Childrens Doctors
8. Changes needed in how federal government evaluates efficiency of research at EPA, other agencies
9. Child Abuse and Neglect Cost Nation over $100 Billion per Year; Most Federal Child Welfare Funds Unavailable for Prevention Services and Programs
10. States Promoted Broader Coverage for Children in 2007, But Report That a Declining Economy Coupled With Lack of SCHIP Reauthorization and New Federal Rules Now Compromise Efforts to Reduce the Number of Uninsured
11. Federal Labor Law Violations Provoke Teamster Strike at AmerisourceBergen Northwest Distribution Hub
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:JAMA study shows what works in treating HIV-infected African children 2Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 2Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 3Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 4Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 5Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 6Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 7Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 8Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 9Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 10Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 11Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 12Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 13Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 14Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 15Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 16Health News:Aetna Reminds Members Affected by California Wildfires Where to Call for Help 2Health News:Aetna Reminds Members Affected by California Wildfires Where to Call for Help 3Health News:New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs 2Health News:New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs 3
Other Medicine Technology:Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10